ELEV — Elevation Oncology Balance Sheet
0.000.00%
Last trade - 00:00
- $144.25m
- $71.00m
- 24
- 24
- 81
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.74 | 79.4 | 146 | 90.3 | 83.1 |
Prepaid Expenses | |||||
Total Current Assets | 1.91 | 80.8 | 149 | 93 | 88 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0.056 | 0.038 | 0.098 | 0.059 |
Other Long Term Assets | |||||
Total Assets | 1.91 | 80.9 | 149 | 94.2 | 89.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.597 | 6.79 | 8.79 | 15.7 | 4.14 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.597 | 6.8 | 8.8 | 45.1 | 34.3 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1.32 | 74.1 | 141 | 49 | 54.8 |
Total Liabilities & Shareholders' Equity | 1.91 | 80.9 | 149 | 94.2 | 89.1 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |